No bidding war for Loxo, so did Lilly overpay?
No bidding war for Loxo, so did Lilly overpay?

19 Jan 2019

Arlene Wb

FIERCE PHARMA

Read More

PhRMA Welcomes Genentech and Gilead Sciences to Association
PhRMA Welcomes Genentech and Gilead Sciences to Association

19 Jan 2019

PR NEWSWIRE

Read More

Second time’s a charm for osteoporosis drug from Amgen, UCB
Second time’s a charm for osteoporosis drug from Amgen, UCB

18 Jan 2019

Natalie Grover

ENDPTS

Read More

Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days
Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days

18 Jan 2019

John Carroll

ENDPTS

Read More

FDA Takes Steps to Make Naloxone an OTC Drug
FDA Takes Steps to Make Naloxone an OTC Drug

18 Jan 2019

Zachary Brennan

RAPS

Read More

FDA Confirms Paragraph IV Patent Challenge of Imbruvica 205552 (Ibrutinib) Capsules
FDA Confirms Paragraph IV Patent Challenge of Imbruvica 205552 (Ibrutinib) Capsules

18 Jan 2019

FDA

Read More

Study links opioid epidemic to painkiller marketing
Study links opioid epidemic to painkiller marketing

18 Jan 2019

Gene Emery

REUTERS

Read More

Just how generous was Celgene in dealmaking? Let’s review the records
Just how generous was Celgene in dealmaking? Let’s review the records

18 Jan 2019

Chris Doko

ENDPTS

Read More

Aptinyx shares crater as lead drug fails in PhII neuropathic pain study
Aptinyx shares crater as lead drug fails in PhII neuropathic pain study

18 Jan 2019

Natalie Grover

ENDPTS

Read More

FDA Advisory Committee Recommends Amgen-UCB Osteoporosis Drug
FDA Advisory Committee Recommends Amgen-UCB Osteoporosis Drug

17 Jan 2019

Ana Mulero

RAPS

Read More

PharmaCompass